Literature DB >> 16440514

Three cases of substitution errors leading to hyoscine hydrobromide overdose.

Diederik K Van Sassenbroeck1, Dimitri M R Hemelsoet, Phyllis Vanwalleghem, Alain G Verstraete, Patrick Santens, Koenraad G Monsieurs, Walter A Buylaert.   

Abstract

We report three patients with anticholinergic poisoning caused by the substitution of hyoscine hydrobromide for hyoscine butylbromide in preparations compounded by two different pharmacists. The patients took the preparations for gastrointes tinal discomfort and presented with altered mental status tachycardia, facial flushing, dilated pupils, and dry skin shortly after the ingestion. In one patient the intoxication was initially not recognized and he was treated as suffering from an acute cerebrovascular accident. Two patients experienced long-lasting effects such as decreased ability to concentrate, memory dis turbances, tremor, and photo- and phonophobia. It was obviously impossible to elucidate the exact nature of the relationship between the intoxication and these long-lasting complaints. Information from the Belgian poison control center revealed that cases of substitution error with hyoscine hydrobromide are not unique The Belgian authorities issued a warning to all pharmacists.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16440514     DOI: 10.1080/15563650500357560

Source DB:  PubMed          Journal:  Clin Toxicol (Phila)        ISSN: 1556-3650            Impact factor:   4.467


  3 in total

1.  Million dollar ride: Crime committed during involuntary scopolamine intoxication.

Authors:  Sonja Reichert; Cassandra Lin; William Ong; Claudia Chon Him; Saadia Hameed
Journal:  Can Fam Physician       Date:  2017-05       Impact factor: 3.275

2.  Anticholinergic syndrome following an unintentional overdose of scopolamine.

Authors:  Carmela E Corallo; Ann Whitfield; Adeline Wu
Journal:  Ther Clin Risk Manag       Date:  2009-09-15       Impact factor: 2.423

3.  Unintentional overdose of hyoscine hydrobromide in a young child.

Authors:  Gerd Xuereb; Thomas Calleja; Janine Borg; David Pace
Journal:  BMJ Case Rep       Date:  2020-02-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.